Yusuf Menda
University of Iowa, IA·Medicine & Clinical Research
Neuroendocrine tumors (NETs) grow from hormone-producing cells scattered through the body. Better ways are needed to detect them, cure them, and eventually prevent them.
- Fields
Medicine & Clinical Research
Public Health & Epidemiology
- Topics
neuroendocrine tumors
neuroendocrine cancer
translational research
- Grants
- 1 known grant, through Jul 2030
What they work on
- Fund two pilot projects each year in neuroendocrine tumor research, spanning population, laboratory, and clinical studies, with continued support for those that make progress.
- Recruit investigators from inside and outside the neuroendocrine tumor field to apply their ideas and methods to the diagnosis, therapy, and prevention of NETs.
- Foster collaboration among basic, population, and clinical scientists, and generate hypotheses for large-scale studies or clinical trials aimed at lowering NET incidence and mortality.
More about the research
Turning laboratory and population findings into longer, better lives for patients requires a steady supply of new ideas, which can then be tested in larger studies.
Why it matters
Patients with neuroendocrine tumors need better diagnosis, curative treatments, and prevention strategies. By funding early-stage ideas and drawing new researchers and techniques into the field, this program aims to produce findings that could eventually improve both the length and quality of life of people with NETs.
Known grants
From NIH and NSF research grants. Labs often have other funding we can't see.
Closest labs
Kimberly Leslie
Washington University in St Louis, MO·Medicine & Clinical Research
Fund up to three one- to two-year pilot projects each year in basic, translational, clinical, epidemiologic and prevention research on endometrial cancer across the three Route 66 SPORE institutions.
Shridar Ganesan
Rutgers University-New Brunswick, NJ·Medicine & Clinical Research
Target metabolic, cell death, and cell survival pathways in cancer and translate promising findings into early-phase clinical trials.
Suzann Duan
University of California-Irvine, CA·Biology·Early-career
Determine whether MEN1-associated gastroenteropancreatic neuroendocrine tumors arise from reprogrammed enteric neural crest-derived cells (gut nervous-system precursor cells), using transgenic mice that lack menin in these cells.
The school
University of Iowa: 32 labs on PI Pages, $703M a year on research, 418 research doctorates a year.
Reach out
A start for your email. Fill in the brackets.